Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (IMOVAX) | SANOFI PASTEUR | UNK | — | OT |
patient received an expired dose of imovax rabies with no reported ae; Initial information received on 13-Feb-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient who received an expired dose of RABIES (HDC) VACCINE [IMOVAX RABIES] with no reported ae (adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received expired RABIES (HDC) VACCINE dose 1 mg Powder and solvent for suspension for injection (strength, batch unknown) expiry-30-Nov-2024 via unknown route in unknown administration site for pre-exposure prophylaxis (Immunization) with no reported ae (expired product administered) (same day latency). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.